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Veen,* A. Struyvenberg,* and Th. J. M. V. Van Vroonhoven^ 
Multiple endocrine neoplasia type 1 (MEN 1) is character-ized by the combined occurrence of tumors of the pitu-
itary gland and pancreatic islets and hyperplasia or adenomas of 
the parathyroid glands. In 1988 the MEN 1 gene was mapped to 
chromosome 11, and it was shown that in insulinomas onco-
genesis involved a recessive mutation at this locus (1). A key 
feature of MEN 1 is the multiple occurrence of tumors within the 
affected glands. It is also possible to observe a complete spec-
tmm of hyperplasia, microadenomas, adenomas, carcinomas, 
and carcinoid changes on pathological examination of those af-
fected glands (2). 
In the Netherlands, with a population of 15 million, 20 fami-
lies totaling about 200 patients with the MEN 1 syndrome have 
been identified. Intensive screening programs have resulted in 
identification of MEN 1 patients at an early age. The patients af-
fected with MEN 1 tend to present with variable clinical pic-
tures. The first manifestation of the disease is usually caused by 
the hyperfunctioning of a single endocrine gland. Further pro-
gression results in hormonal hypersecretion by other glands re-
sulting in a complex clinical syndrome. In this study we report 
the results of screening and management of a large family in the 
Netherlands. 
Patients and Screening Procedures 
The pedigree of family G is shown in the Figure. The follow-
ing screening procedures have been performed annually since 
1985. 
Hyperparathyroidism 
Fasting levels of creatinine, calcium, phosphorus, albumin, 
and intact parathyroid hormone were measured. In selected pa-
tients 24-hour urinary calcium excretion and bone mass mea-
surements were performed. Indications for parathyroid explora-
tion in asymptomatic patients included the finding of a consis-
tently elevated semm calcium level (> 11.4 mg/dL or 2.85 
mmol/L), the presence of kidney stones, reduced creatinine 
clearance, or reduced bone mass measurements. Parathyroid ex-
ploration was also performed in patients with bone, renal, gas-
trointestinal, or neuromuscular symptoms typical for primary 
hyperparathyroidism. Imaging of the parathyroid glands priorto 
initial neck exploration was considered unnecessary. The surgi-
cal procedure performed was total parathyroidectomy and au-
tologous transplantation to the forearm. 
Pituitary gland 
An elevation of serum prolactin concentrations on three sepa-
rate days or from three sequential samples drawn from an in-
dwelling cannula at 30-minute intervals was used to screen for 
prolactinomas. If suspicion of overproduction of ACTH was 
present, a low-dose dexamethasone suppression test or 24-hour 
urine analysis for free Cortisol was utilized to screen for an 
ACTH-producing adenoma. Insulin-like growth factor I and al-
pha subunits of follicle-stimulating hormone and cartilage-hair 
hypoplasia were measured to screen for acromegaly or nonfunc-
tioning adenomas. 
Pancreatic islet cell tumors 
Measurements of glucose, insulin (C-peptide), glucagon, gas-
trin, somatostatin, pancreatic polypeptide, and vasoactive intes-
tinal peptide were performed to screen for pancreatic islet cell 
tumors. Preoperative localization was performed by ultrason-
ography, computed tomography (CT), and, in specific cases, dy-
namic CT angiography and magnetic resonance imaging. Portal 
venous sampling for peptide hormones produced was helpful in 
determining specific hormone production by a tumor. 
Results 
In the G-family, 24 patients were identified as having the 
MEN 1 syndrome (11 females and 13 males). The mean age at 
which negative test results converted to positive was 14 years 
(the youngest was 8 years old, the eldest 17 years old). The natu-
ral history of the MEN 1 syndrome in the G-family showed that 
five patients died of MEN 1-related complications at a mean age 
of 59 years. Death was caused by complications of peptic ulcer 
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Figure—Pedigree ofthe G kindred. 
disease, extensive metastases of pancreatic islet cell and/or en-
docrine gastrointestinal tumors, and renal failure due to hyper-
parathyroidism (HPT). 
Hyperparathyroidism 
Eighteen patients had HPT; 12 patients had surgery: six fe-
males (11-14, ni-5,16,28,29, V-7) and six males (II-6,111-3,4,9, 
IV-7,9). Four patients (11-14,111-3,4,9) were operated on more 
than once; one patient (III-9) was operated on three times. Two 
proven MEN 1 patients (III-2, V-12) had no HPT symptoms or 
signs. The eariiest diagnosis of HPT was in a boy at the age of 10 
years (V-9). 
Pituitary adenomas 
Pituitary adenomas were found in five patients (II-1,111-4,9, 
IV-7, V-12). A prolactinoma was diagnosed in three males who 
have done well on oral bromocriptine (III-9, IV-7, V-12). The 
youngest patient having a microprolactinoma was 14 years old. 
A large nonfunctioning adenoma was found in one patient (III-
4). 
Pancreatic islet cell tumors 
Fifteen patients had pancreatic islet cell tumors (seven fe-
males and eight males). A boy aged 14 years with hypoglycemia 
symptoms was operated on for insulinoma (V-12). Five of the 
males (11-2,6,111-3,4,9) and one female (II-l) had gastrin-pro-
ducing endocrine tumors resulting in the Zollinger-Ellison syn-
drome. Nonsymptomatic hyperplasia or adenomas were seen in 
six females and three males. Pancreatic islet cell carcinomas 
with metastases to the liver were seen in three males (111-2,4,9). 
The entire spectrum of hyperplasia, microadenomas, and adeno-
mas was demonstrated by pathological examination in all surgi-
cal .specimens. 
Conclusions 
In the past, complications of peptic ulcer disease were the 
most common causes of death among untreated MEN 1 patients 
(3,4). Other reported causes of death have been complications 
related to hypoglycemia, disseminated carcinomatosis, renal 
failure secondary to HPT, electrolyte imbalance secondary to 
intractable diarrhea, pituitary insufficiency, and complications 
of pancreatic and pituitary surgery. 
Most patients (10 females and eight males) had HPT and 12 
(six females and six males) underwent surgery. Four had more 
than one operation. 
We observed five patients with pituitary adenomas (one fe-
male and four males). Three patients had prolactin-secreting pi-
tuitary adenomas. 
Pancreatic islet cell tumors were detected in 15 patients (one 
insulinoma, six gastrinomas, and eight nonsymptomatic tu-
mors). 
Periodic examination of MEN 1 families promotes early di-
agnosis and treatment. Screening of families may improve the 
prognosis by facilitating appropriate and timely management 
decisions. 
The prognosis of MEN 1 patients depends on several other 
factors: the stage of the disease at the time of diagnosis, the ag-
gressiveness of tumor growth, and the quality of diagnostic and 
therapeutic procedures. 
Clear oral and written information must be provided to the 
family about clinical symptoms and signs, complications, treat-
ment, prognosis, and inheritance of the syndrome. In addition, 
information obtained from DNA linkage studies is useful be-
cau.se such studies may help to establish predisposition for the 
disease (5). In the near future, the MEN 1 gene will likely be 
identified and DNA diagnosis of gene carrier status in a single 
patient will be possible. However, aside from the biochemical 
questions, the ethical and legal problems of predictive tests have 
to be resolved. 
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